Search Browse Earnings

Avid Bioservices, Inc. — SlamSEC

Avid Bioservices, Inc.

Pharmaceutical Preparations·TUSTIN, CA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

CFO

Hart Daniel R

Revenue

$119.6M

+24.8% YoY

FY 2024

Adj. EBITDA

$19.9M

16.6% margin

FY 2024

Net Income

$127.7M

106.8% margin

FY 2024

EPS (Diluted)

$1.84

FY 2024

Stock Price

—

52W Range

—

P/E Ratio

—

Market Cap

—

Cash

$126.2M

FY 2024

Total Debt

$58.6M

FY 2024

Net Cash

$67.5M

FY 2024

Enterprise Value

—

Debt / EBITDA

-3.4x

FY 2024

EV / EBITDA

—

Employees

—